U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07085650) titled 'The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation' on Dec. 18, 2024.
Brief Summary: Atrial fibrillation (AF) is the most common cardiac arrhythmia in the clinic and can lead to valve regurgitation and a poor prognosis. At present, atrial fibrillation ablation is one of the most effective means for the recurrence of atrial fibrillation in clinical practice, but the recurrence rate is high. Therefore, it is of great significance to find the predictors of relapse after atrial fibrillation ablation for clinical precision treatment. three-dimensional transesophageal ultrasound (3D-T...